Shares of Generate Biomedicines (GENB), an AI-driven drug discovery company, advanced about 12% today. Shares traded at $19.81 in mid-afternoon trading, a gain of $2.09 on the session. The rally ...
AI chip and hardware suppliers that make and sell the equipment data centers run on. Cloud operators, which build and operate data centers and sell access to computing capacity. Their revenue models ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results